Tiverton Asset Management’s X4 Pharmaceuticals XFOR Stock Holding History

Tiverton Asset Management’s Portfolio XFOR Stock Details XFOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$63K	Buy	+165	New	+$65.3K	﹤0.01%	682

Other funds holding XFOR

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Tiverton Asset Management's XFOR Position: Q3 2019 in Review

Tiverton Asset Management opened a new position in X4 Pharmaceuticals (XFOR) in Q3 2019: 165 shares worth $63K. The stake represents ﹤0.01% of the portfolio and ranks #682 among its holdings.

49 funds tracked by Wall St. Rank hold XFOR as of Q3 2019.

Tiverton Asset Management held 165 shares of X4 Pharmaceuticals worth $63K as of Q3 2019.
X4 Pharmaceuticals was a new Tiverton Asset Management position in Q3 2019.
X4 Pharmaceuticals made up ﹤0.01% of Tiverton Asset Management's portfolio in Q3 2019, its #682 holding.
49 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.